TY - JOUR AU - RA Mesa, AU - H Powell, AU - T Lasho, AU - GW DeWald, AU - R McClure, AU - A Tefferi, PY - 2006/03/01 Y2 - 2024/03/29 TI - A longitudinal study of the JAK2(V617F) mutation in myelofibrosis with myeloid metaplasia: analysis at two time points JF - Haematologica JA - haematol VL - 91 IS - 3 SE - Comparative Studies DO - 10.3324/%x UR - https://haematologica.org/article/view/3901 SP - 415-416 AB - Serial analysis for the activating JAK2(V617F) mutation performed in 44 patients with myelofibrosis with myeloid metaplasia showed no interval change in 88% (22/25) of patients over a median interval of 18.6 months. The increase in JAK2 expression observed in three patients did not correspond to disease progression or leukemic transformation. ER -